Health & Fitness
Health and Fitness
Health and Fitness 
Mon, January 31, 2011
Furiex Pharmaceuticals Announces Fourth Quarter 2010 Earnings Release and Conference Call
MORRISVILLE, N.C.--([ BUSINESS WIRE ])--Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) will release its fourth quarter 2010 financial results on Monday, February 21, 2011, after the market closes. The earnings news release will be available on the Furiex website at [ www.furiex.com ].
On Tuesday, February 22, 2011, at 9 a.m. ET, Furiex will conduct a live conference call and audio webcast to discuss financial results and product portfolio. A Q&A session will follow. The conference call will be broadcast live over the Internet and will also be available using the following direct dial numbers:
| |||||||
Participant dial-in: | +1 877 267 0934 (U.S./Canada) | ||||||
| +1 706 643 0961 (International) | ||||||
Conference ID: | 28925775 | ||||||
All interested parties can access the webcast through the Presentations & Events link in the Investors section of the Furiex website at [ www.furiex.com ]. The webcast will be archived shortly after the call for on-demand replay.
About Furiex Pharmaceuticals
Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through the drug discovery and development process in a cost-efficient manner. Development programs are designed and driven by a core team with extensive drug development experience. The company collaborates with pharmaceutical and biotechnology companies and has a strong, diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and two products on the market. The companya™s mission is to develop innovative medicines faster and at less cost, reducing the expense of health care globally while providing life-improving therapies for patients. For more information, visit [ www.furiex.com ].